A 66-year-old man in the United States lived for 271 days without dialysis after receiving a genetically engineered pig kidney, marking a major milestone in organ transplantation. The experimental organ helped Tim Andrews manage end-stage kidney disease while awaiting a human donor kidney. Although the pig kidney eventually failed, Andrews subsequently received a human Kidney Transplant, demonstrating the potential of xenotransplantation as a temporary bridge to conventional transplantation.
The case, reported in September 2026 and detailed in a study published in The Lancet, represents the longest documented dialysis-free survival following pig-kidney transplantation in a living human and the first documented transition from a pig kidney to a human donor kidney.
How a Pig Kidney Kept Tim Andrews Off Dialysis for Nine Months
Tim Andrews, a US resident with end-stage kidney disease associated with type 2 diabetes, received a genetically engineered pig kidney on January 25, 2025.
The transplant was performed by a team associated with Massachusetts General Hospital and Harvard Medical School. At the time of transplantation, Andrews was 66 years old and required a treatment option for advanced kidney failure.
The genetically modified kidney began functioning immediately after transplantation. For 271 days, Andrews remained free from dialysis, allowing the experimental organ to perform the essential kidney functions needed to sustain him while he awaited a human donor.
His case offers an important demonstration of how xenotransplantation—the transplantation of organs from animals into humans—could potentially help patients who face long waiting periods for donor organs.
Why the Pig Kidney Eventually Failed
Although the transplant functioned well for approximately six months, complications eventually developed.
Andrews experienced a bacterial infection that was not transmitted from the pig kidney. Doctors reduced his immunosuppressive medication in response to the infection, after which the transplanted organ developed inflammation and damage affecting its small blood vessels.
The kidney developed a condition known as thrombotic microangiopathy, involving injury to small blood vessels and the formation of microscopic blood clots. The damage progressed, and the pig kidney eventually stopped functioning.
The organ was removed, and Andrews returned to dialysis while awaiting a human kidney transplant.
Human Kidney Transplant Marks Another Milestone
In January 2026, Andrews received a deceased-donor human kidney. The transplanted organ began functioning immediately.
One important finding was that doctors did not observe evidence that the previous pig-kidney transplant had sensitised Andrews’ immune system against the subsequent human donor kidney. His anti-HLA antibody levels had not increased, and follow-up showed no evidence of immune sensitisation affecting the human transplant.
No pig-pathogen transmission was detected during the xenotransplantation period, addressing one of the major safety concerns associated with animal-to-human organ transplantation.
The successful human transplant after the experimental pig kidney is particularly significant because it demonstrates a possible pathway in which xenotransplantation could serve as an interim treatment rather than necessarily being the patient’s final transplant.
What Is Xenotransplantation?
Xenotransplantation refers to the transplantation of living cells, tissues or organs from one species into another. In this case, the procedure involved transplanting a kidney from a genetically engineered pig into a human recipient.
Animal organs cannot simply be transplanted into humans without modification. The human immune system can recognise an animal organ as foreign and mount a response that damages or destroys the transplanted tissue.
Genetic engineering is being used to modify pig organs to reduce immune incompatibility and improve their ability to function in the human body. Researchers are also investigating ways to reduce infection risks and improve the long-term survival of transplanted animal organs.
Although xenotransplantation remains experimental, advances in genetic engineering and transplant medicine have helped researchers move beyond short-term laboratory and preclinical studies toward clinical applications in living patients.
Could Pig Kidneys Help Address the Global Organ Shortage?
One of the biggest challenges in kidney transplantation is the limited availability of suitable human donor organs. Many people with end-stage kidney disease depend on dialysis while waiting for a transplant, and some may never receive a suitable donor organ.
Researchers are investigating whether genetically engineered pig kidneys could eventually help address this shortage.
In the short term, xenotransplantation may offer a potential bridge for selected patients who need kidney replacement but are waiting for a human donor. In the longer term, researchers hope that genetically engineered animal organs could potentially become a more durable treatment option.
However, the 271-day milestone should not be interpreted as proof that pig kidneys are ready to replace conventional human kidney transplants. Long-term safety, organ durability, infection surveillance and immune compatibility remain important challenges.
What This Development Could Mean for India
The achievement has potential relevance for countries such as India, where access to suitable donor organs remains an important healthcare challenge.
In the future, xenotransplantation could potentially provide another treatment option for selected patients with end-stage kidney disease who do not have a suitable living donor and are awaiting a deceased-donor kidney.
However, introducing pig-kidney transplantation into routine clinical practice in India would require substantial scientific, regulatory and healthcare-system preparation.
Key challenges include:
- Long-term graft survival and prevention of organ rejection
- Monitoring and preventing potential animal-to-human infections
- Developing appropriate immunosuppressive treatment strategies
- Establishing regulatory oversight and ethical safeguards
- Ensuring access to genetically engineered animal organs
- Building specialised transplant infrastructure
- Addressing affordability and equitable access
Changes to India’s existing legal and regulatory framework for organ transplantation may also be necessary before xenotransplantation could become part of clinical practice.
Why This Is a Landmark for Transplant Medicine
The significance of Andrews’ case lies not only in the length of time the pig kidney functioned, but also in what happened after the experimental transplant ended.
The case demonstrated that a genetically engineered pig kidney could support a living patient without dialysis for 271 days and that the patient could subsequently receive a human donor kidney without evidence of immune sensitisation caused by the earlier xenotransplant.
It also provided researchers with important information about late-stage complications, including the blood-vessel injury that contributed to the pig kidney’s failure.
These findings may help guide future research into genetic modifications, immunosuppressive treatments and monitoring strategies designed to improve the safety and durability of xenotransplantation.
Conclusion
Tim Andrews’ 271-day survival with a genetically engineered pig kidney represents a significant milestone in xenotransplantation. The experimental organ kept him off dialysis for approximately nine months before it failed, after which he received a human donor kidney.
While the achievement does not mean pig kidneys are ready for widespread clinical use, it provides important proof of concept for using animal organs as a temporary bridge to human transplantation.
Further research will be essential to establish whether xenotransplantation can become a safe, reliable and accessible option for people living with end-stage kidney disease.
SEO Details
Primary Keyword: pig kidney transplant
Secondary Keywords: Tim Andrews pig kidney transplant, xenotransplantation, genetically modified pig kidney, 271-day pig kidney transplant, animal-to-human organ transplant, kidney transplant breakthrough, end-stage kidney disease, dialysis-free survival, human kidney transplant
Meta Title: Man Lives With Pig Kidney for 271 Days in World-First Transplant
Meta Description: A 66-year-old man lived dialysis-free for 271 days with a genetically engineered pig kidney before receiving a human donor transplant, marking a xenotransplantation milestone.
Reference: Research published in The Lancet by Mass General Brigham researchers, detailing Tim Andrews’ 271-day dialysis-free survival following genetically edited pig-kidney transplantation.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Xenotransplantation remains an experimental treatment. Patients with kidney disease should consult a qualified nephrologist or transplant specialist regarding appropriate treatment options.
For breaking news and live news updates, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest Health on thefoxdaily.com.
COMMENTS 0